Research Site

Bad Saarow 15526

4 studies enrolling now · 5 studies all time

What they study most

Benign Giant Cell Tumors, Cancer, Carcinoma, Non-Small Cell Lung, Esophageal Cancer, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, Giant Cell Tumor of Bone, Giant Cell Tumors, HER2-positive Gastric Cancer, Non-small Cell Lung Cancer (NSCLC)

Studies at this site

• A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer — Recruiting now
• Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations — Recruiting now
• Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2 — Recruiting now
• A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer — Recruiting now
• Study of Denosumab in Subjects With Giant Cell Tumor of Bone — Completed